PRCH Physician Helps Convince FDA to Approve New EC
June 17, 2010
After a hearing today, the FDA's Advisory Committee for Reproductive Health Drugs voted unanimously to recommend quick FDA approval for ulipristal acetate, a new form of emergency contraception. Leadership Training Academy alum Sara Imershein, MD, testified before the committee: "We know that more emergency contraception options will improve our care for women." Read Dr. Imershein's complete testimony.
Honor Roe
Sign the Abortion Provider's Declaration of Rights. Stand up for patients seeking abortion and those who provide that care.
Who We Are
PRCH is a doctor-led national advocacy organization. We use evidence-based medicine to promote sound reproductive health policies. We believe in reproductive choice for everyone.
Stay Informed
Most Popular
Choice Words
“I continue to do abortions after 25 years because the voices of gratitude and relief from my patients drown out the hatred and intolerance from the protesters outside.”